Epithelial ovarian cancer: evolution of management in the era of precision medicine
S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …
around the world. The outcomes are complicated, because the disease is often diagnosed …
Clinical actionability of molecular targets in endometrial cancer
ME Urick, DW Bell - Nature Reviews Cancer, 2019 - nature.com
Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …
worldwide. Disease mortality and the increasing number of new diagnoses make …
[HTML][HTML] Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium
K Suda, H Nakaoka, K Yoshihara, T Ishiguro, R Tamura… - Cell reports, 2018 - cell.com
Endometriosis is characterized by ectopic endometrial-like epithelium and stroma, of which
molecular characteristics remain to be fully elucidated. We sequenced 107 ovarian …
molecular characteristics remain to be fully elucidated. We sequenced 107 ovarian …
Mechanisms of PTEN loss in cancer: It's all about diversity
V Álvarez-Garcia, Y Tawil, HM Wise… - Seminars in cancer biology, 2019 - Elsevier
PTEN is a phosphatase which metabolises PIP 3, the lipid product of PI 3-Kinase, directly
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …
Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma
M Köbel, AM Piskorz, S Lee, S Lui… - The Journal of …, 2016 - Wiley Online Library
TP53 mutations are ubiquitous in high‐grade serous ovarian carcinomas (HGSOC), and the
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions
The human body consists of countless cells with the possibility of excessive and
uncontrolled proliferation under certain dysregulated circumstances that could cause …
uncontrolled proliferation under certain dysregulated circumstances that could cause …
[HTML][HTML] Epithelial ovarian cancer
S Sambasivan - Cancer Treatment and Research Communications, 2022 - Elsevier
Epithelial ovarian cancer is the second commonest cause of death amongst all
gynaecological cancers. Treatment is challenging because almost 75% of cases are …
gynaecological cancers. Treatment is challenging because almost 75% of cases are …
[HTML][HTML] Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes
BM Barnes, L Nelson, A Tighe, GJ Burghel, IH Lin… - Genome Medicine, 2021 - Springer
Background Epithelial ovarian cancer (OC) is a heterogenous disease consisting of five
major histologically distinct subtypes: high-grade serous (HGSOC), low-grade serous …
major histologically distinct subtypes: high-grade serous (HGSOC), low-grade serous …
[HTML][HTML] Endometriosis: where are we and where are we going?
AD Greene, SA Lang, JA Kendziorski… - Reproduction …, 2016 - ncbi.nlm.nih.gov
Endometriosis currently affects∼ 5.5 million reproductive-aged women in the US with
symptoms such as painful periods (dysmenorrhea), chronic pelvic pain, pain with …
symptoms such as painful periods (dysmenorrhea), chronic pelvic pain, pain with …
[HTML][HTML] Tumor evolution and chemoresistance in ovarian cancer
Abstract Development of novel strategies to overcome chemoresistance is central goal in
ovarian cancer research. Natural history of the cancer development and progression is …
ovarian cancer research. Natural history of the cancer development and progression is …